27Serious

Charles Smith

Ask VT AI

View News Summary

Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent industry challenges.
Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent industry challenges.
Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Charles Smith